mass cytometry
Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes
Researchers applied a deep-learning approach to generate a model to predict lung cancer progression based on the tumor microenvironment.
CEO Michael Egholm, a former Danaher exec, said he sees Standard BioTools' flaws as emblematic of problems hampering the broader life science tools industry.
Navignostics Using Single-Cell Spatial Proteomics to Guide Oncology Treatment, Drug Development
Premium
The University of Zurich spinout is using Standard BioTools' Hyperion system for its analyses and recently raised CHF 7.5 million in seed funding.
Standard BioTools Q1 Revenues Fall 19 Percent
In Q1 the company formerly known as Fluidigm completed a strategic evaluation process and closed a $250 million capital infusion from Casdin Capital and Viking Global Investors.
Single-Cell Proteomic Analysis Points to Role of Rare Cell Populations in Localized Prostate Cancer
Some rare cell populations identified have been linked to aggressive or metastatic disease.
Aug 5, 2021
Fluidigm Q2 Revenues Grow 19 Percent
Feb 11, 2021
Feb 10, 2021
Aug 4, 2020
Fluidigm, De Novo Software Ink Distribution Deal
May 7, 2020
Fluidigm Q1 Revenues Fall 8 Percent
Feb 10, 2020
Fluidigm Reports Flat Q4 Revenues
Jan 14, 2020